Zobrazeno 1 - 10
of 289
pro vyhledávání: '"Frank A. Lopez"'
Autor:
Stephen V. Faraone, Norberto J. DeSousa, Tayyaba F Khan, Stephanie Rhoten, Frank A. Lopez, Helen Doll, Bev Incledon, Hannah Lewis, Floyd R. Sallee, Jeffrey H. Newcorn
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: Inadequately controlled symptoms and associated impaired functioning have a significant negative impact on caregivers of children with attention-deficit/hyperactivity disorder (ADHD). This study aimed to assess the impact of evening-dosed
Autor:
Jonathan Rubin, Gregory D. Busse, Frank A. Lopez, Tesfaye Liranso, Ann C. Childress, Azmi Nasser, Joseph T. Hull, Zare Melyan
Publikováno v:
Neuropsychiatric Disease and Treatment
Azmi Nasser,1 Joseph T Hull,1 Tesfaye Liranso,2 Gregory D Busse,3 Zare Melyan,3 Ann C Childress,4 Frank A Lopez,5 Jonathan Rubin6 1Department of Clinical Research, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; 2Department of Biostatistics, Supe
Autor:
Gilbert J. Groendyke, Frank G. Lopez
Publikováno v:
2000 Annual Conference Proceedings.
Autor:
Bev Incledon, Valerie Arnold, Floyd R. Sallee, Michelle D. Po, Ann C. Childress, Ryan Gregg, Frank A. Lopez
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 60:S257
Autor:
Frank Verduzco Lopez
Barry Stark was a psychopath that lures his bright greenish eyes on victims. With a promise they can't resist and demands a payment no person could willingly think to pay. The young and vulnerable, the attractive models made the perfect target, the s
Autor:
Kavita Gajria, Emuella Flood, Daniel F. Connor, Paul Hodgkins, Frank A. Lopez, Vanja Sikirica, M. Haim Erder
Publikováno v:
Journal of Health Economics and Outcomes Research
**Background:** Understanding patient and caregiver preferences for treatment is important for optimizing treatment decisions. Non-stimulant therapies are an alternative treatment option to stimulant therapy for attention-deficit/hyperactivity disord
Autor:
Ann C. Childress, Valerie Arnold, Bryan Dirks, John Shepski, Ben Adeyi, Brian Scheckner, Thomas Babcock, Robert A. Lasser, Frank A. Lopez
Publikováno v:
Journal of Attention Disorders. 21:52-61
Objective: To describe symptom rebound in children with ADHD treated with lisdexamfetamine dimesylate (LDX) or placebo. Method: During a 4-week, randomized, double-blind, placebo-controlled trial of LDX, parents/caregivers completed the Conners’ Pa
Publikováno v:
Clinical Therapeutics. 35:1778-1793
Background Guanfacine extended release (GXR) has reported efficacy for the treatment of attention-deficit/hyperactivity disorder (ADHD) as monotherapy and adjunctive therapy to psychostimulant medications. Objective The objective of this article was
Publikováno v:
CNS Spectrums. 15:248-256
Introduction:Lisdexamfetamine dimesylate (LDX) is a prodrug stimulant approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and children 6–12 years of age. Parent surveys provide valuable information regarding the
Autor:
Michael Burton, Frank A. Lopez
Publikováno v:
Journal of Osteopathic Medicine. 118:124-124